|
Alzheimer's disease is reportedly an organic
brain disease with primary lesions within the brain and its etiology remains
for the most part unraveled. However, the current knowledge suggests that
Alzheimer's disease is a disease entity characterized by organic brain
damages at least secondary to some preceding causative event, and the therapeutic
modality so far proposed comprises curing the underlying disease inducing
this organic disturbance of the brain or removing or otherwise disposing
of the pathogenic factor or factors directly involved in the expression
of such organic disturbance.
The underlying disease in Alzheimer's disease is multi-pronged,
including cerebrovascular disorders (e.g. cerebral apoplexy associated
with cerebral hemorrhage and infarction, hypertension, angitis, vascular
anomaly, etc.), degenerative diseases (e.g. Pick's disease, Parkinson's
disease, epilepsy, hydrocephalus, etc.), endocrine diseases (e.g. myxedema,
Addison's disease, hypothyroidism, hypoglycemia, vitamin deficiencies,
etc.), metabolic diseases (e.g. uremia, hepatic disorder, anoxia, etc.),
intoxications (e.g. carbon monoxide poisoning, manganese poisoning, alcoholism,
barbiturism, Korsakoff's syndrome, etc.), infectious diseases (e.g. chronic
encephalitis), tumorigenic diseases (e.g. remote effects of cancer), and
traumatic diseases (e.g. head injury). Referring to the etiologic factors
directly involved in the onset of Alzheimer's disease, the gene abnormality
theory ( Alzheimer gene, Down's syndrome gene, etc.), abnormal protein
deposition theory amyloid protein (senile plaque) theory, neurofibrillary
tangle theory, etc.!, and aluminum accumulation theory have been advanced.
The onset and progression of Alzheimer's disease is considered
to arise from a complicated interaction of the above-mentioned underlying
disease inducing Alzheimer's disease and the etiologic factor or factors
directly inducing the expression of Alzheimer's disease. JP-A-3 81218 (U.S.
Pat. No. 5,059,627) reports that substituted 1,4-benzoquinone derivatives
including idebenone and the corresponding hydroquinone derivatives have
nerve growth factor secretion-inducing activity and are effective in the
treatment of Alzheimer's disease.
JP-A-7 61923 (EP-A-629400) reports that high doses of
idebenone are clinically effective in the therapy of senile dementia of
Alzheimer type.
The Lancet, 340, 671(1992) reports that a combination
therapy using coenzyme Q 10 , an iron preparation, and vitamin B 6 is effective
in the therapy and inhibition of progression of familial Alzheimer's disease.
JP-A-1 221316 discloses a nootropic composition comprising idebenone in
combination with vinpocetine. However, no report is available on a therapeutic
or prophylactic medication for Alzheimer's disease that ever employs idebenone
in combination with other medicinal substances. For the method of treating
and preventing Alzheimer's disease involving a multiplicity of etiologic
factors as mentioned above, therapeutic drugs for the underlying diseases
have been used independently for symptomatic relief only with limited success.
Moreover, the only symptomatic remedy for Alzheimer's disease that has
been available so far is tacrine (1,2,3,4-tetrahydro-9-acridinamine hydrochloride)
and donepezil (2,3-dihydro-5,6-dimethoxy-2- 1-(phenylmethyl)-4-piperidinyl!methyl!-1H-i
nden-1-one hydrochloride) which, however, have the drawback of hepatotoxicity
and/or other cholinergic side effects.
Shilajit
&
Withania Somnifera combination has been proven to be extremely
beneficial in brain degenerative ailments of Alzheimer's and Parkinson's
diseases. Withania Somnifera is also known as Indian Ginseng
and Ashwagandha.
Research
by Paul Flechsig Institute Brain Res., Department of Neurochemistry, University
of Leipzig, D-04109 Leipzig Germany has shown that the combination
of Shilajit and Withania Somnifera is very powerful in enhancing
cognition and memory in Alzheimer's patients. Please
click here to know more. We are pleased to
offer a combination of Shilajit & Withania Somnifera.
|
Order
Shilajit & Withania Somnifera
|
If
any of your near or dear one is afflicted by Alzheimer's we strongly recommend
Shilajit & Withania Somnifera combination. This will boost the quality
of life and ease the burden. The mails and phone calls we get in this regard
thanking us gives immense happiness to us. This combination has been proven
to be very effective in preventing, arresting and reversing Alzheimer's
and Parkinson's conditions. If you any of your near one is above 60 years
you can recommend them Withania Somnifera and Shilajit as a preventive
dose.
As
such anyone can take this combination for it's memory and stamina boosting
effects. Shilajit (Fulvic acid) is a known anti aging elixir. Shilajit
and
Withania Somnifera combination serve as a powerful nervine &
cerebral tonic fortifying brain cells against degeneration. This combination
can surely prevent the onset of any brain degenerative disease like Alzheimer's,
Parkinson's, dementia etc.
4 Packets
of Shilajit& 4 Bottles of Withania Somnifera- 4 Months Course
 |
U.S.$ 84 |
Free
delivery worldwide - direct to your door
<
Home
Shilajit
Fulvic Acid
Shilajit Vidoes
Ashwagandha
Site Map
|
|